Literature DB >> 8599910

Aspiration cytology of chromophobe cell carcinoma of the kidney.

M Akhtar1, M A Ali.   

Abstract

Fine-needle aspiration biopsy findings in three cases of chromophobe cell carcinoma are described and correlated with histologic and ultrastructural observations. In addition, comparisons are made with three cases each of oncocytoma and granular cell carcinoma. The cells in aspiration smears from chromophobe cell carcinoma closely correlated with histologic pattern of three cell types which were not present in oncocytomas and granular cell carcinomas. These cells had prominent cell borders, and their cytoplasm was either opaque and granular (type I) or variably translucent and reticular (type II and III). Ultrastructurally, the translucent areas within the cytoplasm contained large numbers of microvesicles which were unique to chromophobe cell carcinoma and were not seen in other neoplasms. Fine-needle aspiration may be used to diagnose chromophobe cell carcinoma and distinguish it from other related renal neoplasms.

Entities:  

Mesh:

Year:  1995        PMID: 8599910     DOI: 10.1002/dc.2840130403

Source DB:  PubMed          Journal:  Diagn Cytopathol        ISSN: 1097-0339            Impact factor:   1.582


  3 in total

1.  Typing of renal tumors by morphological and immunocytochemical evaluation of fine needle aspirates.

Authors:  Margareta Strojan Fležar; Helena Gutnik; Jera Jeruc; Irena Srebotnik Kirbiš
Journal:  Virchows Arch       Date:  2011-11-04       Impact factor: 4.064

2.  Chromophobe renal cell carcinoma: useful diagnostic application of imprint cytology and fluorescence in situ hybridization of chromosomes 10 and 21 in two cases of typical and eosinophilic variants.

Authors:  Naoto Kuroda; Kazunobu Katto; Tadanori Yamaguchi; Takako Kawada; Yoshiaki Imamura; Ondrej Hes; Michal Michal; Taro Shuin; Gang-Hong Lee
Journal:  Med Mol Morphol       Date:  2008-12-24       Impact factor: 2.309

Review 3.  Imaging and management of the incidentally discovered renal mass.

Authors:  Jonathon Willatt; Isaac R Francis
Journal:  Cancer Imaging       Date:  2009-10-02       Impact factor: 3.909

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.